Dupilumab-Associated Blepharoconjunctivitis: Clinical and Morphological Aspects
Purpose: To describe the clinical and morphologic changes in the ocular surface microstructure of patients affected with moderate-to-severe Atopic Dermatitis (AD) before and during Dupilumab treatment. Methods: This is a monocentric observational study on thirty-three patients affected with AD befor...
Main Authors: | Federica Serino, Valeria Dattilo, Michela Cennamo, Anna Maria Roszkowska, Massimo Gola, Manfredi Magliulo, Elisabetta Magnaterra, Rita Mencucci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/12/3104 |
Similar Items
-
Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
by: Vingopoulos F, et al.
Published: (2020-07-01) -
Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients
by: Tauqeer Z, et al.
Published: (2022-03-01) -
Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01) -
Dupilumab side effect in a patient with atopic dermatitis: a case report study
by: Albader SS, et al.
Published: (2019-05-01) -
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)